Advertisement

Advancing Care in Achondroplasia: From Diagnosis to Clinical Evidence and Patient-Centered Care - Episode 3

Recognizing the Multisystem Burden of Achondroplasia

Published on: 
, ,

Beyond short stature, achondroplasia carries life-threatening risks at the skull base. The panel details why foramen magnum stenosis, hydrocephalus, and airway obstruction demand vigilant monitoring from infancy onward.

In “Recognizing the Multisystem Burden of Achondroplasia,” our panel explores the clinical manifestations and complications that make achondroplasia much more than a disorder of short stature. The discussion begins with the experience of families receiving an unexpected diagnosis, particularly because many children with achondroplasia are born to parents without a prior family history of the condition. The panel emphasizes the importance of early education while avoiding overwhelming families with too much information at once.

Particular attention is given to complications involving the skull base. The experts explain that foramen magnum narrowing is an important concern in infancy because severe stenosis can compress the brainstem or spinal cord and affect movement or breathing. In some children, surgical decompression may be required. The panel also discusses the potential for hydrocephalus and the importance of monitoring head circumference, fontanelle findings, and development.

Moving anteriorly, midface hypoplasia can contribute to eustachian tube dysfunction, recurrent otitis media, hearing impairment, and subsequent effects on language development. Adenoid and tonsillar crowding may also increase the risk of obstructive sleep apnea across infancy, childhood, and adulthood. Throughout the discussion, the panel stresses the value of structured surveillance and early education. Children with achondroplasia can be followed much like other children, but they require additional monitoring targeted to the known complications associated with the condition.

Our next episode, “Redefining Treatment Success in Achondroplasia Beyond Height,” shifts the discussion from disease burden to treatment goals. The panel will consider which outcomes matter most to clinicians, patients, and families when evaluating whether treatment is successful.

Advertisement
Advertisement